What is the share price of Infinium Pharmachem Ltd (INFINIUM) today?
The share price of INFINIUM as on 19th June 2025 is ₹295.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Infinium Pharmachem Ltd (INFINIUM) share?
The past returns of Infinium Pharmachem Ltd (INFINIUM) share are- Past 1 week: 2.30%
- Past 1 month: -4.50%
- Past 3 months: 32.73%
- Past 6 months: -4.12%
- Past 1 year: 33.42%
- Past 3 years: N/A%
- Past 5 years: 295.13%
What are the peers or stocks similar to Infinium Pharmachem Ltd (INFINIUM)?
The peers or stocks similar to Infinium Pharmachem Ltd (INFINIUM) include:What is the market cap of Infinium Pharmachem Ltd (INFINIUM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Infinium Pharmachem Ltd (INFINIUM) is ₹455.03 Cr as of 19th June 2025.What is the 52 week high and low of Infinium Pharmachem Ltd (INFINIUM) share?
The 52-week high of Infinium Pharmachem Ltd (INFINIUM) is ₹392.50 and the 52-week low is ₹178.05.What is the PE and PB ratio of Infinium Pharmachem Ltd (INFINIUM) stock?
The P/E (price-to-earnings) ratio of Infinium Pharmachem Ltd (INFINIUM) is 55.83. The P/B (price-to-book) ratio is 7.55.Which sector does Infinium Pharmachem Ltd (INFINIUM) belong to?
Infinium Pharmachem Ltd (INFINIUM) belongs to the Materials sector & Commodity Chemicals sub-sector.How to buy Infinium Pharmachem Ltd (INFINIUM) shares?
You can directly buy Infinium Pharmachem Ltd (INFINIUM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Infinium Pharmachem Ltd
INFINIUM Share Price
INFINIUM Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
INFINIUM Performance & Key Metrics
INFINIUM Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 7.55 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
27.05 | 3.44 | 1.61% |
INFINIUM Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
INFINIUM Company Profile
The Company is involved in the development, manufacture, and export of a spectrum of the Iodine Derivatives that are used in pharmaceutical, chemical, biotech and allied industries across the globe.
INFINIUM Forecast
INFINIUM Forecasts
INFINIUM
INFINIUM
Income
Balance Sheet
Cash Flow
INFINIUM Income Statement
INFINIUM Income Statement
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 39.41 | 71.15 | 100.05 | 115.57 | 137.18 | 157.83 | — | |||||||
Raw Materials | 31.18 | 57.91 | 78.36 | 80.17 | 108.05 | 139.29 | — | |||||||
Power & Fuel Cost | 0.32 | 0.50 | 0.77 | 0.63 | 1.12 | |||||||||
Employee Cost | 2.09 | 2.75 | 3.54 | 5.37 | 5.91 | |||||||||
Selling & Administrative Expenses | 2.89 | 6.03 | 7.31 | 10.19 | 5.07 | |||||||||
Operating & Other expenses | -0.12 | -1.62 | -0.89 | 1.82 | -3.04 | |||||||||
EBITDA | 3.05 | 5.58 | 10.96 | 17.39 | 20.07 | 18.54 | — | |||||||
Depreciation/Amortization | 0.58 | 0.65 | 0.63 | 1.34 | 2.67 | 3.29 | — | |||||||
PBIT | 2.47 | 4.93 | 10.33 | 16.05 | 17.40 | 15.25 | — | |||||||
Interest & Other Items | 1.24 | 1.16 | 1.70 | 3.10 | 2.19 | 3.67 | — | |||||||
PBT | 1.23 | 3.77 | 8.63 | 12.95 | 15.21 | 11.58 | — | |||||||
Taxes & Other Items | 0.30 | 1.05 | 2.53 | 3.47 | 3.90 | 3.43 | — | |||||||
Net Income | 0.93 | 2.72 | 6.10 | 9.48 | 11.31 | 8.15 | — | |||||||
EPS | 0.23 | 0.67 | 1.50 | 2.33 | 4.14 | 5.60 | — | |||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
INFINIUM Company Updates
INFINIUM Stock Peers
INFINIUM Past Performance & Peer Comparison
INFINIUM Past Performance & Peer Comparison
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Infinium Pharmachem Ltd | 55.83 | 7.55 | — |
Solar Industries India Ltd | 127.93 | 45.14 | 0.06% |
Linde India Ltd | 131.55 | 17.25 | — |
Deepak Nitrite Ltd | 37.39 | 5.41 | 0.39% |
INFINIUM Stock Price Comparison
Compare INFINIUM with any stock or ETFINFINIUM Holdings
INFINIUM Shareholdings
INFINIUM Promoter Holdings Trend
INFINIUM Promoter Holdings Trend
INFINIUM Institutional Holdings Trend
INFINIUM Institutional Holdings Trend
No institutional holdings trend are available
INFINIUM Shareholding Pattern
INFINIUM Shareholding Pattern
INFINIUM Shareholding History
INFINIUM Shareholding History
smallcases containing INFINIUM stock
smallcases containing INFINIUM stock
Looks like this stock is not in any smallcase yet.
INFINIUM Events
INFINIUM Events
INFINIUM Dividend Trend
INFINIUM has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
INFINIUM Dividend Trend
INFINIUM has not given any dividends in last 5 years
INFINIUM Dividends
INFINIUM Dividends
INFINIUM Stock News & Opinions
INFINIUM Stock News & Opinions
Infinium Pharmachem will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
Infinium Pharmachem will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Infinium Pharmachem announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 23 October 2024 .Powered by Capital Market - Live
Infinium Pharmachem will hold a meeting of the Board of Directors of the Company on 1 October 2024.Powered by Capital Market - Live
Infinium Pharmachem will hold a meeting of the Board of Directors of the Company on 2 September 2024.Powered by Capital Market - Live
In last 6 months, promoter holding in the company has decreased by 7.81%
Pledged promoter holdings is insignificant